- Home
- MRVI vs JMSB Comparison
MRVI vs JMSB Comparison
Compare MRVI & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- JMSB
- Stock Information
- Founded
- MRVI 2014
- JMSB 2005
- Country
- MRVI United States
- JMSB United States
- Employees
- MRVI N/A
- JMSB N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- JMSB Major Banks
- Sector
- MRVI Health Care
- JMSB Finance
- Exchange
- MRVI Nasdaq
- JMSB Nasdaq
- Market Cap
- MRVI 312.4M
- JMSB 282.0M
- IPO Year
- MRVI 2020
- JMSB N/A
- Fundamental
- Price
- MRVI $2.20
- JMSB $18.91
- Analyst Decision
- MRVI Hold
- JMSB Buy
- Analyst Count
- MRVI 10
- JMSB 2
- Target Price
- MRVI $6.84
- JMSB $22.50
- AVG Volume (30 Days)
- MRVI 1.5M
- JMSB 22.0K
- Earning Date
- MRVI 08-11-2025
- JMSB 07-23-2025
- Dividend Yield
- MRVI N/A
- JMSB 1.61%
- EPS Growth
- MRVI N/A
- JMSB 687.32
- EPS
- MRVI N/A
- JMSB 1.32
- Revenue
- MRVI $241,856,000.00
- JMSB $56,750,000.00
- Revenue This Year
- MRVI N/A
- JMSB N/A
- Revenue Next Year
- MRVI $10.70
- JMSB N/A
- P/E Ratio
- MRVI N/A
- JMSB $14.15
- Revenue Growth
- MRVI N/A
- JMSB 59.00
- 52 Week Low
- MRVI $1.67
- JMSB $13.81
- 52 Week High
- MRVI $9.95
- JMSB $26.52
- Technical
- Relative Strength Index (RSI)
- MRVI 42.78
- JMSB 52.31
- Support Level
- MRVI $1.99
- JMSB $18.65
- Resistance Level
- MRVI $2.40
- JMSB $18.98
- Average True Range (ATR)
- MRVI 0.16
- JMSB 0.46
- MACD
- MRVI -0.06
- JMSB -0.07
- Stochastic Oscillator
- MRVI 25.15
- JMSB 46.11
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.